High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Salie, Ruduwaan ^a   Huisamen, Barbara ^a   Lochner, Amanda ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Cardioprotection; Diet induced obesity; High fat diet; Infarct size; Insulin resistance; Obesity; RISK pathway

Indexed keywords

FORMOTEROL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SUCROSE; CARBOHYDRATE DIET;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME ACTIVATION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; LIPID DIET; MALE; NONHUMAN; OBESITY; RAT; REPERFUSION INJURY; ADMINISTRATION AND DOSAGE; ANIMAL; DIET THERAPY; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PROCEDURES; WISTAR RAT;

ANIMALS; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; MALE; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR;

EID: 84925883988     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-014-0109-8     Document Type: Article

References (50)

1. Chase PJ, Davis PG, Bensimhon DR: The obesity paradox in chronic heart failure: what does it mean? Curr Heart Fail Rep 2014,Epub ahead of print.
2. Clark AL, Fonarow GC, Horwich TB: Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis 2014, 56:409-410.
3. Diercks DB, Roe MT, Mulgund J, Pollack CV Jr, Kirk JD, Gibler WB, Ohman EM, Smith SC Jr, Boden WE, Peterson ED: The obesity paradox in non-ST-segment elevation acute coronary syndromes. Am Heart J 2006, 152:140-148.
4. Miki T, Itoh T, Sunaga D, Miura T: Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol 2012, 11:67.
5. Whittington HJ, Babu GG, Mocanu NM, Yellon DM, Hausenloy DJ: The diabetic heart: too sweet for its own good? Cardiol Res Pract 2012, 2012:845698. doi: 10.1155/2012/845698.
6. Balakumar P, Singh H, Singh M, Anand-Srivastava MB: The impairment of preconditioning-mediated cardioprotection in pathological conditions. Pharmacol Res 2009, 60:18-23.
7. Jones SP, Girod WG, Granger DN, Palazzo AJ, Lefer DJ: Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart. Am J Physiol Heart Circ Physiol 1999, 277:H763-H769.
8. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC: Diabetes abolishes ischemic preconditioning: role of glucose, insulin and osmolality. Am J Physiol 2000, 278:H1218-H1224.
9. Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K: Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart. Diabetes 2002, 51:1110-1117.
10. Marfella R, D'Amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, Berrino L, Rossi F, Giugliano D: Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 2002, 45:1172-1181.
11. Hadour G, Ferrera R, Sebbag L, Forrat R, Delaye J, de Lorgeril M: Improved myocardial tolerance to ischaemia in the diabetic rabbit. J Mol Cell Cardiol 1998, 30:1869-1875.
12. Ma G, Al-Shabrawey M, Johnson JA, Datar R, Tawfik HE, Guo D, Caldwell RB, Caldwell RW: Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density and activation of cell survival signalling. Naunyn Schmiedebergs Arch Pharmacol 2006, 373:415-427.
13. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JTE, Nielsen TT, Botker HE, Flyvbjerg A: Ischaemic preconditioning does not protect the heart in obese and lean animal models and type 2 diabetes. Diabetologia 2004, 47:1716-1721.
14. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM: Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 2004, 54:2360-2364.
15. Gurel E, Ustunova S, Kapucu A, Yilmazer N, Eerbeek O, Nederlof R, Hollman MW, Demirci-Tansel C, Zuurbier CJ: Hexokinase cellular trafficking in ischemia-reperfusion and ischaemic preconditioning is altered in type 1 diabetic heart. Mol Biol Rep 2013, 40:1753-1760.
16. Ebel D, Mullenheim J, Frassdorf J, Heinen A, Huhn R, Bohlen R, Ferrari J, Sudkamp H, Preckel B, Schlack W, Thamer V: Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischemic late preconditioning in the rabbit heart in vivo. Pflugers Archiv 2003, 446:175-182.
17. Matsumoto S, Cho S, Tosaka S, Ureshino H, Maekawa T, Hara T, Sumikawa K: Pharmacological preconditioning in type 2 diabetic rat hearts: the roles of mitochondrial ATP-sensitive potassium channels and the phosphatidylinositol 3-kinase-Akt pathway. Cardiovasc Drugs Therap 2000, 23:263-270.
18. Clark C, Smith W, Lochner A, du Toit EF: The effects of gender and obesity on myocardial tolerance to ischemia. Physiol Res 2011, 60:291-301.
19. Wensley I, Salaveria K, Bulmer AC, Donner DG, du Toit EF: Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance. Exp Physiol 2013, 98:1552-1564.
20. Du Toit EF, Smith W, Muller C, Strijdom H, Stouthammer B, Woodiwiss A, Norton GR, Lochner A: Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity. Am J Physiol Heart Circ Physiol 2008, 294:H2336-H2343.
21. Nduhirabandi F, du Toit EF, Blackhurst D, Marais D, Lochner A: Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischaemia and reperfusion injury in a pre-diabetic model of diet-induced obesity. J Pineal Res 2011, 50:171-192.
22. Maarman G, Marais E, Lochner A, du Toit EF: Effect of chronic CPT-1 inhibition on myocardial ischaemia-reperfusion injury (I/R) in a model of diet-induced obesity. Cardiovasc Drugs Therap 2012, 26:305-316.
23. Thakker GD, Frangogiannis NG, Zymek PT, Sharma S, Saumya S, Raya JL, Barger PM, Taegtmeyer H, Entman ML, Ballantyne CM: Increased myocardial succeptibility to repetitive ischemia with high fat diet-induced obesity. Obesity 2008, 16:2593-2600.
24. Bouhidel O, Pons S, Souktani R, Berdeaux A, Ghaleh B: Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol 2008, 295:H1580-H1586.
25. Granado M, Fernandez N, Monge L, Figueras JC, Carreno-Tarragona G, Amor S, Garcia-Villalon AL: Effects of coronary ischemia-reperfusion in a rat model of early overnutrition: role of angiotensin receptors. PLoS One 2013, 8:e54984.
26. Katakam PV, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW: Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 2007, 292:R920-R926.
27. Donner D, Headrick JP, Peart JN, du Toit EF: Obesity improves myocardial ischemic tolerance and RISK signalling in insulin-insensitive rats. Dis Mod Mech 2013, 6:457-466.
28. Balakumar P, Sharma NK: Healing the diabetic heart: does myocardial preconditioning work? Cell Signal 2012, 24:53-59.
29. Bouchard JF, Lamontagne D: Protection afforded by preconditioning to the diabetic heart against ischaemic injury. Cardiovasc Res 1998, 37:82-90.
30. Tatsumi T, Matoba S, Kobara M, Keira N, Kawahara A, Tsuruyama K, Tanaka T, Katamura M, Nakagawa C, Ohta B, Yamahara Y, Asayama J, Nakagawa M: Energy metabolism after ischaemic preconditioning in streptozotocin-induced diabetic rat hearts. J Am Coll Cardiol 1998, 31:707-715.
31. Liu Y, Thornton JD, Cohen MY, Downey JM, Schaffer SW: Streptozotocin-induced non-insulin dependent diabetes protects the heart from infarction. Circulation 1993, 88:1273-1278.
32. Ravingerova T, Stetka R, Pancza D, Ulicna O, Ziegelkoffer A, Styk J: Susceptibility to ischemia-induced arrhythmias and the effect of preconditioning in the diabetic rat heart. Physiol Res 2000, 49:607-616.
33. Vinokur V, Berenshtein E, Bulvik B, Grinberg L, Eliashar R, Chevion M: The bitter fate of the sweet heart: impairment of iron homeostasis in diabetic heart leads to failure in myocardial protection by preconditioning. PLos One 2013, 8:e62948.
34. Hausenloy D, Tsang A, Mocanu MM, Yellon DM: Ischemic preconditioning protects by activating prosurvival kinses at reperfusion. Am J Physiol Heart Circ Physiol 2005, 288:H971-H976.
35. Hausenloy DJ, Yellon DM: Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 2007, 12:217-234.
36. Huisamen B: Protein kinase B in the diabetic heart. Mol Cell Biochem 2003, 249:31-38.
37. Xu G, Takashi E, Udo M, Ishiwata T, Naito S: Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signalling pathway. Exp Mol Pathol 2004, 76:57-65.
38. Strniskova M, Barancik M, Neckar J, Ravingerova T: Mitogen-activated protein kinases in the acute diabetic myocardium. Mol Cell Biochem 2003, 249:59-65.
39. Pickavance LC, Tadayyon M, Widdowson PS, Buckingham RE, Wilding JPH: Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution. Brit J Pharmacol 1999, 128:1570-1576.
40. Lochner A, Genade S, Tromp E, Podzuweit T, Moolman JA: Ischaemic preconditioning and the beta-adrenergic signal transduction pathway. Circulation 1999, 100:958-966.
41. Lochner A, Genade S, Moolman JA: Ischaemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol 2003, 98:337-346.
42. Salie R, Moolman JA, Lochner A: The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation. Basic Res Cardiol 2012, 107:281-303.
43. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
44. Du Toit EF, Nabben M, Lochner A: A potential role for angiotensin II in obesity-induced cardiac hypertrophy and ischaemic /reperfusion injury. Basic Res Cardiol 2005, 100:346-354.
45. Wilson CR, Tran MK, Salazar KL, Young ME, Taegtmeyer H: Western diet but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. Biochem J 2007, 406:457-467.
46. Harmancey R, Vasquez HG, Guthrie PH, Taegtmeyer H: Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart. FASEB Journal 2013, 27:3966-3978.
47. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, Abel ED: Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 2004, 53:2366-2374.
48. Buchanan J, Mazumder PK, Ping H, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED: Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 2005, 146:5341-5349.
49. Van der Mieren G, Nevelsteen I, Vanderper A, Oosterlinck W, Flameng W, Herigers P: Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury. Cardiovasc Diabetol 2012, 11:89. doi: 10.1186/1475-2840-11-89.
50. Van der Mieren G, Nevelsteen I, Vanderper A, Oosterlonck W, Flameng W, Herigers P: Angiotensin-converting enzyme inhibition and food restriction restore delayed preconditioning in diabetic mice. Cardiovasc Diabetol 2013, 12:36. http://www.cardiab.com/content/12/1/36.